Duration of sweat cyclophosphamide excretion in patients undergoing a conditioning regimen of high-dose cyclophosphamide for hematopoietic stem-cell transplantation.

Tanigawa, Hiromu; Hirohara, Masayoshi; Marutani, Yoshinori; Suzuki, Yuji; Onizuka, Makoto; Oda, Shiori; Orita, Mutsuko; Sato, Masayo; Kushida, Kazuki

Tanigawa, Hiromu; Hirohara, Masayoshi; Marutani, Yoshinori; Suzuki, Yuji; Onizuka, Makoto; Oda, Shiori; Orita, Mutsuko; Sato, Masayo; Kushida, Kazuki.

Afiliação

Tanigawa H; 26391Showa Pharmaceutical University.
Hirohara M; 26391Showa Pharmaceutical University.
Marutani Y; Division of Pharmacy, 38261Tokai University Medical Hospital.
Suzuki Y; Division of Pharmacy, 38261Tokai University Medical Hospital.
Onizuka M; Division of Hematology, 38261Tokai University Medical Hospital.
Oda S; Division of Nursing, 38261Tokai University Medical Hospital.
Orita M; Division of Nursing, 38261Tokai University Medical Hospital.
Sato M; Division of Nursing, 38261Tokai University Medical Hospital.
Kushida K; 26391Showa Pharmaceutical University.

J Oncol Pharm Pract ; 29(3): 619-625, 2023 Apr.

Article em En | MEDLINE | ID: mdl-35089101

Assuntos

Transplante de Células-Tronco Hematopoéticas; Suor; Humanos; Cromatografia Líquida; Espectrometria de Massas em Tandem; Ciclofosfamida; Condicionamento Pré-Transplante

Palavras-chave

Antineoplastic agent; cyclophosphamide; environmental contamination; occupational exposure; sweat

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 12_ODS3_hazardous_contamination Base de dados: MEDLINE Assunto principal: Suor / Transplante de Células-Tronco Hematopoéticas Limite: Humans Idioma: En Revista: J Oncol Pharm Pract Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google